SALD-7500nano Expands Measurement of Nanoparticles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

SALD-7500nano Expands Measurement of Nanoparticles


Pharmaceutical Technology
Volume 38, Issue 3, pp. 14

Shimadzu introduces the SALD-7500nano, a particle size analyzer that can measure nanoparticles in low concentrations or those that demonstrate high light absorption. The system is capable of a wide measurement range, from primary particles to sub-visible particles and contaminants, and allows measurements across a concentration range from 0.01 ppm to 20%. It enables measurement of micro bubbles from 100 nm to 60 μm and real-time tracking of changes in bubble diameter. The SALD-7500nano features a single light source and wide-angle detection method, allowing high-speed measurement to a minimum of one second and real-time display of particle size distribution at one-second intervals. The system uses an omnidirectional shock absorption frame to improve instrument stability and provide high reproducibility, while built-in self-diagnostic functions ensure easy maintenance.

Shimadzu Scientific Instruments

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: Pharmaceutical Technology,
Click here